Identification and Copy Number Variant Analysis of Enhancer Regions of Genes Causing Spinocerebellar Ataxia
Authors:
- Fatemeh GhorbaniFGFatemeh Ghorbani
- Eddy N. de BoerEBEddy N. de Boer
- Michiel R. FokkensMFMichiel R. Fokkens
- Jelkje de Boer-BergsmaJBJelkje de Boer-Bergsma
- Corien C. Verschuuren-BemelmansCVCorien C. Verschuuren-Bemelmans
- Elles WierengaEWElles Wierenga
- Hamidreza KasaeiHKHamidreza Kasaei
- Daan NoordermeerDNDaan Noordermeer
- Dineke S. VerbeekDVDineke S. Verbeek
- Helga WestersHWHelga Westers
- Cleo C. van DiemenCDCleo C. van Diemen
Open Access
- 18 October 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (20) , 11205
Abstract
Currently, routine diagnostics for spinocerebellar ataxia (SCA) look for polyQ repeat expansions and conventional variations affecting the proteins encoded by known SCA genes. However, ~40% of the patients still remain without a genetic diagnosis after routine tests. Increasing evidence suggests that variations in the enhancer regions of genes involved in neurodegenerative disorders can also cause disease. Since the enhancers of SCA genes are not yet known, it remains to be determined whether variations in these regions are a cause of SCA. In this pilot project, we aimed to identify the enhancers of the SCA genes ATXN1, ATXN3, TBP and ITPR1 in the human cerebellum using 4C-seq, publicly available datasets, reciprocal 4C-seq, and luciferase assays. We then screened these enhancers for copy number variants (CNVs) in a cohort of genetically undiagnosed SCA patients. We identified two active enhancers for each of the four SCA genes. CNV analysis did not reveal any CNVs in the enhancers of the four SCA genes in the genetically undiagnosed SCA patients. However, in one patient, we noted a CNV deletion with an unknown clinical significance near one of the ITPR1 enhancers. These results not only reveal elements involved in SCA gene regulation but can also lead to the discovery of novel SCA-causing genetic variants. As enhancer variations are being increasingly recognized as a cause of brain disorders, screening the enhancers of ATXN1, ATXN3, TBP and ITPR1 for variations other than CNVs and identifying and screening enhancers of other SCA genes might elucidate the genetic cause in undiagnosed patients.Keywords
All Related Versions
Funding Information
- Rosalind Franklin Fellowship from University Medical Center of Groningen (DSV)
- PhD grant from the Graduate School of Medical Science of the University of Groningen (FG)
This publication has 46 references indexed in Scilit:
- Study of Linc00574 Regulatory Effect on the TCTE3 Expression in Sperm MotilityReproductive Sciences, 2020
- Long noncoding RNA BHLHE40‐AS1 promotes early breast cancer progression through modulating IL‐6/STAT3 signalingJournal of Cellular Biochemistry, 2020
- Molecular Mechanisms and Therapeutics for SCA17Neurotherapeutics, 2019
- Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine NeuronsThe American Journal of Human Genetics, 2018
- Spinocerebellar ataxia: an updateJournal of Neurology, 2018
- A Pentanucleotide ATTTC Repeat Insertion in the Non-coding Region of DAB1, Mapping to SCA37, Causes Spinocerebellar AtaxiaThe American Journal of Human Genetics, 2017
- A Regulatory Archipelago Controls Hox Genes Transcription in DigitsCell, 2011
- An ITPR1 gene deletion causes spinocerebellar ataxia 15/16: A genetic, clinical and radiological descriptionMovement Disorders, 2010
- Two Italian Families with ITPR1 Gene Deletion Presenting a Broader Phenotype of SCA15The Cerebellum, 2010
- Investigations of the effect of DNA size in transient transfection assay using dual luciferase systemAnalytical Biochemistry, 2005